Astrocytoma, IDH-Mutant

general

An astrocytoma associated with IDH1 or IDH2 gene mutations and absence of 1p/19q codeletion. It is classified as grade 2, 3, or 4.

47

Centers

66

Active Trials

$12.8B

Cancer Funding

Specific Cancer Types(3)

NameCenters
Astrocytoma, IDH-Mutant, Grade 439
Recurrent Astrocytoma, IDH-Mutant17
Astrocytoma, Grade II6

Top Centers for Astrocytoma, IDH-Mutant(47)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
The University of Texas MD Anderson Cancer CenterHouston, TX
NCI Comprehensive
Active Research Program
62.5
2
Duke Cancer InstituteDurham, NC
NCI Comprehensive
Active Research Program
62.5
3
Huntsman Cancer Institute at the University of UtahSalt Lake City, UT
NCI Comprehensive
Active Research Program
62.5
4
Cleveland Clinic Cancer CenterCleveland, OH
Active Research Program
62.5
5
Memorial Sloan Kettering Cancer CenterNew York, NY
NCI Comprehensive
—
6
Dana-Farber Cancer InstituteBoston, MA
NCI Comprehensive
—
7
Fred Hutch Cancer CenterSeattle, WA
NCI Comprehensive
—
8
Stanford Cancer InstitutePalo Alto, CA
NCI Comprehensive
—
9
Siteman Cancer CenterSt. Louis, MO
NCI Comprehensive
—
10
Mayo Clinic Comprehensive Cancer CenterRochester, MN
NCI Comprehensive
—
11
Yale Cancer Center Yale School of MedicineNew Haven, CT
NCI Comprehensive
—
12
Vanderbilt-Ingram Cancer CenterNashville, TN
NCI Comprehensive
—
13
Herbert Irving Comprehensive Cancer CenterNew York, NY
NCI Comprehensive
—
14
UC San Diego Moores Cancer CenterLa Jolla, CA
NCI Comprehensive
—
15
The University of Chicago Medicine Comprehensive Cancer CenterChicago, IL
NCI Comprehensive
—
16
Simmons Comprehensive Cancer Center UT Southwestern Medical CenterDallas, TX
NCI Comprehensive
—
17
Laura and Isaac Perlmutter Cancer Center at NYU Langone HealthNew York, NY
NCI Comprehensive
—
18
Winship Cancer InstituteAtlanta, GA
NCI Comprehensive
—
19
The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH
NCI Comprehensive
—
20
University of Wisconsin Carbone Cancer CenterMadison, WI
NCI Comprehensive
—
21
City of Hope Comprehensive Cancer CenterDuarte, CA
NCI Comprehensive
—
22
University of Colorado Cancer CenterAurora, CO
NCI Comprehensive
—
23
Moffitt Cancer CenterTampa, FL
NCI Comprehensive
—
24
UC Davis Comprehensive Cancer CenterSacramento, CA
NCI Comprehensive
—
25
Roswell Park Comprehensive Cancer CenterBuffalo, NY
NCI Comprehensive
—
26
University of Virginia Cancer CenterCharlottesville, VA
NCI Comprehensive
—
27
Sylvester Comprehensive Cancer CenterMiami, FL
NCI Clinical
—
28
The University of Arizona Cancer CenterTucson, AZ
NCI Comprehensive
—
29
UCI Chao Family Comprehensive Cancer CenterOrange, CA
NCI Comprehensive
—
30
Medical College of Wisconsin Cancer CenterMilwaukee, WI
—
31
Cedars-Sinai CancerLos Angeles, CA
—
32
VCU Massey Comprehensive Cancer CenterRichmond, VA
NCI Comprehensive
—
33
Holden Comprehensive Cancer CenterIowa City, IA
NCI Comprehensive
—
34
Fred & Pamela Buffett Cancer CenterOmaha, NE
NCI Clinical
—
35
The University of Kansas Cancer CenterKansas City, KS
NCI Comprehensive
—
36
Dartmouth Cancer CenterLebanon, NH
NCI Comprehensive
—
37
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
—
38
University of Illinois Cancer CenterChicago, IL
—
39
UAMS Winthrop P. Rockefeller Cancer InstituteLittle Rock, AR
—
40
Boston University Cancer CenterBoston, MA
—
41
Cancer Center at IllinoisUrbana, IL
—
42
University of Cincinnati Cancer CenterCincinnati, OH
—
43
Mayo Clinic Comprehensive Cancer Center, FloridaJacksonville, FL
—
44
Mayo Clinic Comprehensive Cancer Center, ArizonaScottsdale, AZ
—
45
University of Puerto Rico Comprehensive Cancer CenterSan Juan, PR
—
46
University of Texas Medical Branch Cancer CenterGalveston, TX
—
47
Louisiana Cancer Research CenterNew Orleans, LA
—

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →